carbamates has been researched along with Niemann-Pick Diseases in 2 studies
Niemann-Pick Diseases: A group of autosomal recessive disorders in which harmful quantities of lipids accumulate in the viscera and the central nervous system. They can be caused by deficiencies of enzyme activities (SPHINGOMYELIN PHOSPHODIESTERASE) or defects in intracellular transport, resulting in the accumulation of SPHINGOMYELINS and CHOLESTEROL. There are various subtypes based on their clinical and genetic differences.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Civallero, G | 1 |
| De Mari, J | 1 |
| Bittar, C | 1 |
| Burin, M | 1 |
| Giugliani, R | 1 |
| Rosenbaum, AI | 1 |
| Cosner, CC | 1 |
| Mariani, CJ | 1 |
| Maxfield, FR | 1 |
| Wiest, O | 1 |
| Helquist, P | 1 |
2 other studies available for carbamates and Niemann-Pick Diseases
| Article | Year |
|---|---|
Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
Topics: Carbamates; Cells, Cultured; Cholesterol Ester Storage Disease; Dried Blood Spot Testing; Fibroblast | 2014 |
Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics.
Topics: Carbamates; Cell Line; Enzyme Reactivators; Humans; Kinetics; Lipase; Lysosomes; Morpholines; Nieman | 2010 |